ATE216707T1 - Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises - Google Patents

Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises

Info

Publication number
ATE216707T1
ATE216707T1 AT97900735T AT97900735T ATE216707T1 AT E216707 T1 ATE216707 T1 AT E216707T1 AT 97900735 T AT97900735 T AT 97900735T AT 97900735 T AT97900735 T AT 97900735T AT E216707 T1 ATE216707 T1 AT E216707T1
Authority
AT
Austria
Prior art keywords
celiac
celiaic
peptides
therapy
diseases
Prior art date
Application number
AT97900735T
Other languages
English (en)
Inventor
Vincenzi Massimo De
Original Assignee
Ist Superiore Sanita
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ist Superiore Sanita filed Critical Ist Superiore Sanita
Application granted granted Critical
Publication of ATE216707T1 publication Critical patent/ATE216707T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT97900735T 1996-01-26 1997-01-16 Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises ATE216707T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96RM000052A IT1283899B1 (it) 1996-01-26 1996-01-26 Peptidi e loro usi nella terapia della malattia celiaca
PCT/IT1997/000007 WO1997027217A1 (en) 1996-01-26 1997-01-16 Peptides and uses thereof for therapy of celiac diseases

Publications (1)

Publication Number Publication Date
ATE216707T1 true ATE216707T1 (de) 2002-05-15

Family

ID=11403826

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97900735T ATE216707T1 (de) 1996-01-26 1997-01-16 Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises

Country Status (6)

Country Link
EP (1) EP0876399B1 (de)
AT (1) ATE216707T1 (de)
AU (1) AU1318797A (de)
DE (1) DE69712182T2 (de)
IT (1) IT1283899B1 (de)
WO (1) WO1997027217A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6348495B1 (en) 1996-06-06 2002-02-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Method for treating celiac disease
US8092794B2 (en) * 2006-03-15 2012-01-10 Isocell Pharma S.A. Pharmaceutical compositions comprising SODs and prolamine based peptide fragments
FR2925328B1 (fr) * 2007-12-21 2011-08-12 Vincience Utilisation d'un hydrolysat de kamut en tant que principe actif activateur de la synthese des aquaporines
JP5867598B2 (ja) * 2011-05-26 2016-02-24 谷 亞紀子 自閉症の治療薬
ITRM20110487A1 (it) 2011-09-19 2013-03-20 Consiglio Per La Ricerca E La Speri Mentazione In Peptidi aventi effetto protettivo nei confronti della attività infiammatoria del peptide 31-43 della a-gliadina nella malattia celiaca.
ES2402286B1 (es) 2011-09-29 2014-03-04 Universidad De Valladolid Péptido inmunogénico del gluten y sus aplicaciones.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826765A (en) * 1986-10-24 1989-05-02 The United States Of America As Represented By The Secretary Of The Agriculture Yeast strains genetically engineered to produce wheat gluten proteins
WO1994026774A1 (en) * 1993-05-19 1994-11-24 Cytel Corporation Novel treatments for allergic diseases

Also Published As

Publication number Publication date
EP0876399A1 (de) 1998-11-11
ITRM960052A0 (it) 1996-01-26
AU1318797A (en) 1997-08-20
WO1997027217A1 (en) 1997-07-31
IT1283899B1 (it) 1998-05-07
DE69712182D1 (de) 2002-05-29
ITRM960052A1 (it) 1997-07-26
EP0876399B1 (de) 2002-04-24
DE69712182T2 (de) 2002-11-21

Similar Documents

Publication Publication Date Title
DE69326064T2 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
DK1521774T3 (da) Trunkerede Tau-proteiner
ATE354638T1 (de) Menschlicher gewebsinhibitor von metalloproteinase-4
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69838544D1 (de) Isolierung von gewebspezifischen peptidliganden und ihre verwendung zur ausrichtung von pharmazeutika auf zielorgane
DE69526216T2 (de) Antifungaleverfahren und mitteln
DE69938786D1 (de) Die verwendung von peptiden von il-2 und peptid-derivaten als therapeutische wirkstoffe
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
ATE191922T1 (de) Feststellung der wechselwirkungsstelle zwischen p21-waf und pcna und deren therapeutischen verwendungen
BR9607628A (pt) Mólecula proteinácea biologicamente isolada, molécula recombinante, fragmento de peptìdeo, molécula de ácido nucleico, composição farmacêutica, e, processos para preparar uma molécula recombinante e para induzir a proliferação astroglial em um mamìfero
FI940375A (fi) Peptidit, joilla on elimiä suojaavaa vaikutusta, menetelmä niiden valmistamiseksi ja niiden käyttö terapiassa
NO963487L (no) Isolerte, tyrosinaseavledete peptider, samt anvendelser derav
ATE197403T1 (de) Methoden zur detektion und behandlung von individuen mit abnormalen hla-a2/tyrosinase- peptidantigenen exprimierenden zellen
ATE253117T1 (de) Adenovirus e4 proteine für induktion von zelltod
ATE216707T1 (de) Peptide und ihre verwendung in der therapie von krankheiten des zöliakie-formenkreises
ATE251886T1 (de) Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit
AU2579995A (en) Alpha b crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
EA199901061A1 (ru) Новые соли врс-пептидов с органопротективной активностью, способ их получения и их использование в терапии
ATE300554T1 (de) Bindegewebe-wachstumsfaktor 3.
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
ATE30238T1 (de) N-acylderivate von peptiden, ihre herstellung und verwendung bei der bekaempfung von krankheiten und mittel dafuer.
KR100194283B1 (ko) B형 간염 바이러스에 대한 인체 면역조절기능을 가진 x 단백질 유래의 펩타이드
TH31634A (th) เพพไทด์ชนิดใหม่ที่เหมาะสมสำหรับใช้ในการบำบัดรักษาที่กดภูมิคุ้มกันที่มีความจำเพาะต่อแอนติเจน

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties